Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction

被引：6

作者：

Attaya, Shariff ^{[1
,2
]}

Kanthi, Yogendra ^{[1
,2
]}

Aster, Richard ^{[3
]}

McCrae, Keith ^{[1
,2
]}

机构：

[1] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA

[2] Univ Hosp Cleveland, Cleveland, OH 44106 USA

[3] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA

来源：

PLATELETS | 2009年 / 20卷 / 01期

关键词：

Eptifibatide; immune thrombocytopenia; thrombocytopenia; ABCIXIMAB;

D O I：

10.1080/09537100802592676

中图分类号：

Q2 [细胞生物学];

学科分类号：

071013 [干细胞生物学];

摘要：

We present a case of eptifibatide-induced acute profound thrombocytopenia in a 64-year-old male receiving eptifibatide for the second time during percutaneous coronary intervention. Although rare, short and self-limited episodes of acute and profound thrombocytopenia have been associated with eptifibatide exposure. The thrombocytopenia is thought to be immune mediated, and assays are available to test for eptifibatide-induced platelet antibodies.

引用

页码：64 / 67

页数：4

共 15 条

[1]

ACC/AHA 2007 Guidelines for the Management of Patients With unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [J].

Anderson, Jeffrey L. ;

Adams, Cynthia D. ;

Antman, Elliott M. ;

Bridges, Charles R. ;

Califf, Robert M. ;

Casey, Donald E., Jr. ;

Chavey, William E. ;

Fesmire, Francis M. ;

Hochman, Judith S. ;

Levin, Thomas N. ;

Lincoff, A. Michael ;

Peterson, Eric D. ;

Theroux, Pierre ;

Wenger, Nanette Kass ;

Wright, R. Scott ;

Smith, Sidney C. ;

Jacobs, Alice K. ;

Halperin, Jonathan L. ;

Hunt, Sharon A. ;

Krumholz, Harlan M. ;

Kushner, Frederick G. ;

Lytle, Bruce W. ;

Nishimura, Rick ;

Ornato, Joseph P. ;

Page, Richard L. ;

Riegel, Barbara .

CIRCULATION, 2007, 116 (07) :E148-E304

[2]

Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors [J].

Aster, RH ;

Curtis, BR ;

Bougie, DW ;

Dunkley, S ;

Greinacher, A ;

Warkentin, TE ;

Chong, BH .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (03) :678-679

[3]

Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors [J].

Aster, RH .

CHEST, 2005, 127 (02) :53S-59S

[4]

Current concepts - Drug-induced immune thrombocytopenia [J].

Aster, Richard H. ;

Bougie, Daniel W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (06) :580-587

[5]

Berkowitz SD, 1997, CIRCULATION, V95, P809

[6]

Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa [J].

Bougie, DW ;

Wilker, PR ;

Wuitschick, ED ;

Curtis, BR ;

Malik, M ;

Levine, S ;

Lind, RN ;

Pereira, J ;

Aster, RH .

BLOOD, 2002, 100 (06) :2071-2076

[7]

USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[8]

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug [J].

Curtis, BR ;

Divgi, A ;

Garritty, M ;

Aster, RH .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (06) :985-992

[9]

Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists [J].

Huxtable, LM ;

Tafreshi, MJ ;

Rakkar, ANS .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (03) :426-429

[10]

KARLHEINZ P, 1999, AM J CARDIOL, V84, P519

← 1 2 →